Dr. Reiners specializes in general obstetrics and gynecology. She received her medical degree from the University of California, San Diego and completed her residency at the University of California, Los Angeles. She also holds a Master of Public Health degree from the University of California, Los Angeles and has been involved in numerous public health projects focused on reproductive health. At Stanford, she provides inpatient and outpatient obstetrical and gynecologic care to women of all ages and is also involved with medical education, serving as the Co-Director of the Obstetrics and Gynecology Core Clerkship for the Stanford University School of Medicine.

Clinical Focus

  • Obstetrics and Gynecology
  • Pregnancy
  • Breastfeeding
  • Contraception
  • Minimally Invasive Surgery
  • Abnormal Pap Test
  • Abnormal bleeding
  • Fibroids
  • Vaginal Infections
  • Infertility

Academic Appointments

Administrative Appointments

  • Co-Director, Obstetrics & Gynecology Core Clerkship (2018 - Present)

Boards, Advisory Committees, Professional Organizations

  • Member, American College of Obstetrics and Gynecology (2008 - Present)

Professional Education

  • Board Certification: Obstetrics and Gynecology, American Board of Obstetrics and Gynecology (2017)
  • Medical Education: University of California San Diego School of Medicine Registrar (2011) CA
  • Board Certification, American Board of Obstetrics and Gynecology (2017)
  • Residency: University of California Los Angeles (2015) CA


All Publications

  • Unmasking of PML by HAART: Unusual clinical features and the role of IRIS JOURNAL OF NEUROIMMUNOLOGY Sidhu, N., McCutchan, J. 2010; 219 (1-2): 100–104


    For patients with HIV/AIDS, highly active antiretroviral therapy (HAART) is currently the only effective therapy for progressive multifocal leukoencephalopathy (PML), a viral-induced demyelinating disease caused by polyomavirus JC. Immune reconstitution inflammatory syndrome (IRIS) following initiation of HAART can cause paradoxical clinical deterioration in patients with established PML. Because the onset of PML follows soon after initiation of HAART in some cases (unmasking), we investigated the role IRIS plays in unmasked PML. We reviewed records of 20 PML cases seen from 1997-2006 at the UCSD HIV primary care clinic. Eight cases presented with PML symptoms within 6months of initiating HAART (referred to hereafter as unmasked PML), six patients were diagnosed with PML before initiating HAART, and six were diagnosed more than 6months after starting HAART. Patients with unmasked PML constituted 40% of our series, had relatively long survival, and commonly (50%) had lesions exclusively in the posterior fossa, a localization not previously reported with such a high prevalence. Only 3 of the 8 patients with unmasked PML had IRIS reactions as evidenced by contrast enhancement around lesions on MRI, suggesting that IRIS is not necessary for the pathogenesis of this syndrome.

    View details for PubMedID 19962769